In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 5th, 2008 | 27 | Yes |
Popular Name: SB 203580 SB 203580
Find On: PubMed — Wikipedia — Google
CAS Numbers: 152121-44-3; 152121-47-6 , 152121-47-6 , 152121-47-6; 869185-85-3 , 869185-85-3 , [152121-47-6]
4-(4'-Fluorophenyl)-2-(4'-methylsulphinylphenyl)-5-(4'-pyridyl)imidazole
4-(4-(4-Fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine
4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazol
4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-
4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-(4-pyridyl)-1H-imidazole
Pyridine, 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.10 | 8.81 | -16.64 | 1 | 4 | 0 | 59 | 377.444 | 4 | ↓ |
Ref Reference (pH 7) | 3.10 | 8.8 | -16.98 | 1 | 4 | 0 | 59 | 377.444 | 4 | ↓ |
Lo Low (pH 4.5-6) | 3.10 | 9.25 | -46.22 | 2 | 4 | 1 | 60 | 378.452 | 4 | ↓ |
Lo Low (pH 4.5-6) | 3.10 | 9.24 | -46.37 | 2 | 4 | 1 | 60 | 378.452 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | p38 MAPK | Selleck Chemicals |
Indications | protein kinase inhibitor | KeyOrganics Bioactives |
Notes | Selective inhibitor of p38 MAP kinase. Inhibitor of p40 kinase . | Apollo Scientific Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ACV1B-1-E | Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.29 | Binding ≤ 10μM |
ADCK4-1-E | Uncharacterized AarF Domain-containing Protein Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
BRAF-1-E | Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic | Eukaryotes | 710 | 0.32 | Binding ≤ 10μM |
CTRO-1-E | Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 420 | 0.33 | Binding ≤ 10μM |
DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
DDR2-1-E | Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.27 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 710 | 0.32 | Binding ≤ 10μM |
EPHA6-1-E | Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
EPHB2-1-E | Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7800 | 0.26 | Binding ≤ 10μM |
FRK-1-E | Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4400 | 0.28 | Binding ≤ 10μM |
GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 39 | 0.38 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
KC1AL-1-E | Casein Kinase I Isoform Alpha-like (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 37 | 0.39 | Binding ≤ 10μM |
KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 220 | 0.35 | Binding ≤ 10μM |
KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 320 | 0.34 | Binding ≤ 10μM |
KS6A6-1-E | Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 250 | 0.34 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 7800 | 0.26 | Binding ≤ 10μM |
M4K4-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.28 | Binding ≤ 10μM |
MK08-1-E | Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 95 | 0.36 | Binding ≤ 10μM |
MK10-2-E | C-Jun N-terminal Kinase 3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 90 | 0.37 | Binding ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 78 | 0.37 | Binding ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 56 | 0.38 | Binding ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 56 | 0.38 | Binding ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 72 | 0.37 | Binding ≤ 10μM |
MLTK-1-E | Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4400 | 0.28 | Binding ≤ 10μM |
MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9600 | 0.26 | Binding ≤ 10μM |
MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.27 | Binding ≤ 10μM |
MRCKB-1-E | Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2700 | 0.29 | Binding ≤ 10μM |
MRCKG-1-E | Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.33 | Binding ≤ 10μM |
NLK-1-E | Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 25 | 0.39 | Binding ≤ 10μM |
PGH1-1-E | Cyclooxygenase-1 (cluster #1 Of 6), Eukaryotic | Eukaryotes | 2000 | 0.30 | Binding ≤ 10μM |
PTK6-1-E | Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9000 | 0.26 | Binding ≤ 10μM |
Q5SC61-1-E | Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.36 | Binding ≤ 10μM |
RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 980 | 0.31 | Binding ≤ 10μM |
RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 24 | 0.40 | Binding ≤ 10μM |
SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4600 | 0.28 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5300 | 0.27 | Binding ≤ 10μM |
ST32B-1-E | Serine/threonine-protein Kinase 32B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
STK36-1-E | Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 860 | 0.31 | Binding ≤ 10μM |
TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7100 | 0.27 | Binding ≤ 10μM |
TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.28 | Binding ≤ 10μM |
TNIK-1-E | TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 820 | 0.32 | Binding ≤ 10μM |
TTK-1-E | Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2500 | 0.29 | Binding ≤ 10μM |
TXK-1-E | Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4500 | 0.28 | Binding ≤ 10μM |
LOX5-1-E | Arachidonate 5-lipoxygenase (cluster #1 Of 7), Eukaryotic | Eukaryotes | 80 | 0.37 | Functional ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
TNFA-1-E | TNF-alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 70 | 0.37 | Functional ≤ 10μM |
Z100081-1-O | PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other | Other | 80 | 0.37 | Functional ≤ 10μM |
Z102116-1-O | Toxoplasma Gondii RH (cluster #1 Of 2), Other | Other | 8500 | 0.26 | Functional ≤ 10μM |
Z50472-1-O | Toxoplasma Gondii (cluster #1 Of 4), Other | Other | 2500 | 0.29 | Functional ≤ 10μM |
Z50587-1-O | Homo Sapiens (cluster #1 Of 9), Other | Other | 940 | 0.31 | Functional ≤ 10μM |
Z80523-1-O | SW1353 (cluster #1 Of 2), Other | Other | 50 | 0.38 | Functional ≤ 10μM |
Z80548-1-O | THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other | Other | 72 | 0.37 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 130 | 0.36 | Binding ≤ 1μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 290 | 0.34 | Binding ≤ 1μM |
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 120 | 0.36 | Binding ≤ 1μM |
KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 100 | 0.36 | Binding ≤ 1μM |
CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 420 | 0.33 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 340 | 0.34 | Binding ≤ 1μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 1000 | 0.31 | Binding ≤ 1μM |
MK14_MOUSE | P47811 | MAP Kinase P38 Alpha, Mouse | 136 | 0.36 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 10 | 0.41 | Binding ≤ 1μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 10 | 0.41 | Binding ≤ 1μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 10 | 0.41 | Binding ≤ 1μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 10 | 0.41 | Binding ≤ 1μM |
Q5SC61_TOXGO | Q5SC61 | Mitogen-activated Protein Kinase 1, Toxgo | 100 | 0.36 | Binding ≤ 1μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 320 | 0.34 | Binding ≤ 1μM |
KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 250 | 0.34 | Binding ≤ 1μM |
NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 25 | 0.39 | Binding ≤ 1μM |
STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 860 | 0.31 | Binding ≤ 1μM |
BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 530 | 0.33 | Binding ≤ 1μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 135 | 0.36 | Binding ≤ 1μM |
MRCKG_HUMAN | Q6DT37 | Serine/threonine-protein Kinase MRCK Gamma, Human | 400 | 0.33 | Binding ≤ 1μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 330 | 0.34 | Binding ≤ 1μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 16 | 0.40 | Binding ≤ 1μM |
TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 820 | 0.32 | Binding ≤ 1μM |
ACV1B_HUMAN | P36896 | Activin Receptor Type-1B, Human | 3000 | 0.29 | Binding ≤ 10μM |
MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 1100 | 0.31 | Binding ≤ 10μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 130 | 0.36 | Binding ≤ 10μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 290 | 0.34 | Binding ≤ 10μM |
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 120 | 0.36 | Binding ≤ 10μM |
KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 100 | 0.36 | Binding ≤ 10μM |
KC1AL_HUMAN | Q8N752 | Casein Kinase I Isoform Alpha-like, Human | 1700 | 0.30 | Binding ≤ 10μM |
CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 420 | 0.33 | Binding ≤ 10μM |
PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 2000 | 0.30 | Binding ≤ 10μM |
DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 5000 | 0.27 | Binding ≤ 10μM |
MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 9600 | 0.26 | Binding ≤ 10μM |
TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 2500 | 0.29 | Binding ≤ 10μM |
EPHA6_HUMAN | Q9UF33 | Ephrin Type-A Receptor 6, Human | 1200 | 0.31 | Binding ≤ 10μM |
EPHB2_HUMAN | P29323 | Ephrin Type-B Receptor 2, Human | 6800 | 0.27 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1300 | 0.31 | Binding ≤ 10μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 1000 | 0.31 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 1700 | 0.30 | Binding ≤ 10μM |
MK14_MOUSE | P47811 | MAP Kinase P38 Alpha, Mouse | 136 | 0.36 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 10 | 0.41 | Binding ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 10 | 0.41 | Binding ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 10 | 0.41 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 10 | 0.41 | Binding ≤ 10μM |
Q5SC61_TOXGO | Q5SC61 | Mitogen-activated Protein Kinase 1, Toxgo | 100 | 0.36 | Binding ≤ 10μM |
M4K4_HUMAN | O95819 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4, Human | 3700 | 0.28 | Binding ≤ 10μM |
MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 4400 | 0.28 | Binding ≤ 10μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 320 | 0.34 | Binding ≤ 10μM |
KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 250 | 0.34 | Binding ≤ 10μM |
NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 25 | 0.39 | Binding ≤ 10μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 3700 | 0.28 | Binding ≤ 10μM |
ST32B_HUMAN | Q9NY57 | Serine/threonine-protein Kinase 32B, Human | 2100 | 0.29 | Binding ≤ 10μM |
STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 1300 | 0.31 | Binding ≤ 10μM |
BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 530 | 0.33 | Binding ≤ 10μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 135 | 0.36 | Binding ≤ 10μM |
MRCKB_HUMAN | Q9Y5S2 | Serine/threonine-protein Kinase MRCK Beta, Human | 2700 | 0.29 | Binding ≤ 10μM |
MRCKG_HUMAN | Q6DT37 | Serine/threonine-protein Kinase MRCK Gamma, Human | 400 | 0.33 | Binding ≤ 10μM |
MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 6200 | 0.27 | Binding ≤ 10μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 2000 | 0.30 | Binding ≤ 10μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 16 | 0.40 | Binding ≤ 10μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 3500 | 0.28 | Binding ≤ 10μM |
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 6000 | 0.27 | Binding ≤ 10μM |
TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 1800 | 0.30 | Binding ≤ 10μM |
TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 1500 | 0.30 | Binding ≤ 10μM |
PTK6_HUMAN | Q13882 | Tyrosine-protein Kinase BRK, Human | 3900 | 0.28 | Binding ≤ 10μM |
FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 1800 | 0.30 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 2800 | 0.29 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 5000 | 0.27 | Binding ≤ 10μM |
TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 4500 | 0.28 | Binding ≤ 10μM |
ADCK4_HUMAN | Q96D53 | Uncharacterized AarF Domain-containing Protein Kinase 4, Human | 3100 | 0.29 | Binding ≤ 10μM |
LOX5_HUMAN | P09917 | Arachidonate 5-lipoxygenase, Human | 80 | 0.37 | Functional ≤ 10μM |
Z50587 | Z50587 | Homo Sapiens | 2000 | 0.30 | Functional ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 1000 | 0.31 | Functional ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 1000 | 0.31 | Functional ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 1000 | 0.31 | Functional ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 1000 | 0.31 | Functional ≤ 10μM |
Z100081 | Z100081 | PBMC (Peripheral Blood Mononuclear Cells) | 160 | 0.35 | Functional ≤ 10μM |
Z80523 | Z80523 | SW1353 | 50 | 0.38 | Functional ≤ 10μM |
Z80548 | Z80548 | THP-1 (Acute Monocytic Leukemia Cells) | 16 | 0.40 | Functional ≤ 10μM |
TNFA_HUMAN | P01375 | TNF-alpha, Human | 70 | 0.37 | Functional ≤ 10μM |
Z50472 | Z50472 | Toxoplasma Gondii | 2500 | 0.29 | Functional ≤ 10μM |
Z102116 | Z102116 | Toxoplasma Gondii RH | 8500 | 0.26 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of BIM and translocation to mitochondria | |
Activation of BMF and translocation to mitochondria | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
ARMS-mediated activation | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
Ca2+ pathway | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Circadian Clock | |
Constitutive PI3K/AKT Signaling in Cancer | |
COX reactions | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Degradation of beta-catenin by the destruction complex | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
Downregulation of TGF-beta receptor signaling | |
Downstream TCR signaling | |
DSCAM interactions | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK/MAPK targets | |
ERK2 activation | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
Frs2-mediated activation | |
GAB1 signalosome | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Generation of second messenger molecules | |
Golgi Associated Vesicle Biogenesis | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
KSRP destabilizes mRNA | |
L1CAM interactions | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MEK activation | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
NOD1/2 Signaling Pathway | |
Non-integrin membrane-ECM interactions | |
NRAGE signals death through JNK | |
NRIF signals cell death from the nucleus | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
p75NTR recruits signalling complexes | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
Platelet sensitization by LDL | |
PLCG1 events in ERBB2 signaling | |
RAF activation | |
RAF phosphorylates MEK | |
Rap1 signalling | |
Recruitment of mitotic centrosome proteins and complexes | |
Recycling pathway of L1 | |
Regulation of HSF1-mediated heat shock response | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by NODAL | |
RSK activation | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
Senescence-Associated Secretory Phenotype (SASP) | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by Activin | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by FGFR | |
Signaling by NODAL | |
Signaling by SCF-KIT | |
Signalling to p38 via RIT and RIN | |
SMAD2/3 MH2 Domain Mutants in Cancer | |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
Spry regulation of FGF signaling | |
Stimuli-sensing channels | |
Synthesis of 5-eicosatetraenoic acids | |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | |
Synthesis of Lipoxins (LX) | |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | |
T41 mutants of beta-catenin aren't phosphorylated | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
TGF-beta receptor signaling activates SMADs | |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
TGFBR1 KD Mutants in Cancer | |
TGFBR1 LBD Mutants in Cancer | |
TGFBR2 Kinase Domain Mutants in Cancer | |
TGFBR2 MSI Frameshift Mutants in Cancer | |
TNF signaling | |
Transcriptional regulation of white adipocyte differentiation | |
Translocation of ZAP-70 to Immunological synapse | |
truncations of AMER1 destabilize the destruction complex | |
Uptake and function of anthrax toxins | |
VEGFA-VEGFR2 Pathway | |
WNT mediated activation of DVL |
No pre-computed analogs available. Try a structural similarity search.